Skip to main content
Erschienen in: Journal of General Internal Medicine 4/2016

01.04.2016 | Original Research

Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events

verfasst von: Jamal S. Rana, MD, PhD, Jennifer Y. Liu, MPH, Howard H. Moffet, MPH, Marc Jaffe, MD, Andrew J. Karter, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

For more than a decade, the presence of diabetes has been considered a coronary heart disease (CHD) “risk equivalent”.

Objective

The objective of this study was to revisit the concept of risk equivalence by comparing the risk of subsequent CHD events among individuals with or without history of diabetes or CHD in a large contemporary real-world cohort over a period of 10 years (2002 to 2011).

Design

Population-based prospective cohort analysis.

Participants

We studied a cohort of 1,586,061 adult members (ages 30–90 years) of Kaiser Permanente Northern California, an integrated health care delivery system.

Main Measurements

We calculated hazard ratios (HRs) from Cox proportional hazard models for CHD among four fixed cohorts, defined by prevalent (baseline) risk group: no history of diabetes or CHD (None), prior CHD alone (CHD), diabetes alone (DM), and diabetes and prior CHD (DM + CHD).

Key Results

We observed 80,012 new CHD events over the follow-up period (~10,980,800 person-years). After multivariable adjustment, the HRs (reference: None) for new CHD events were as follows: CHD alone, 2.8 (95 % CI, 2.7–2.85); DM alone 1.7 (95 % CI, 1.66–1.74); DM + CHD, 3.9 (95 % CI, 3.8–4.0). Individuals with diabetes alone had significantly lower risk of CHD across all age and sex strata compared to those with CHD alone (12.2 versus 22.5 per 1000 person-years). The risk of future CHD for patients with a history of either DM or CHD was similar only among those with diabetes of long duration (≥10 years).

Conclusions

Not all individuals with diabetes should be unconditionally assumed to be a risk equivalent of those with prior CHD.
Literatur
1.
Zurück zum Zitat American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2012;36:1033–46. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2012;36:1033–46.
2.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–234.CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–234.CrossRefPubMed
3.
Zurück zum Zitat Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486–97. Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486–97.
4.
Zurück zum Zitat Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935–2959.CrossRefPubMed Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935–2959.CrossRefPubMed
5.
Zurück zum Zitat Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? systematic review and meta-analysis. Diabet Med. 2009;26:142–148.CrossRefPubMed Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? systematic review and meta-analysis. Diabet Med. 2009;26:142–148.CrossRefPubMed
6.
Zurück zum Zitat Wong ND. Is diabetes really a coronary heart disease risk equivalent? Cardiovasc Endocrinol. 2012;1:65–67.CrossRef Wong ND. Is diabetes really a coronary heart disease risk equivalent? Cardiovasc Endocrinol. 2012;1:65–67.CrossRef
7.
Zurück zum Zitat Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161:1717–1723.CrossRefPubMed Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161:1717–1723.CrossRefPubMed
8.
Zurück zum Zitat Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011;171:404–410.CrossRefPubMed Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011;171:404–410.CrossRefPubMed
9.
Zurück zum Zitat Daniels LB, Grady D, Mosca L, Collins P, et al. Raloxifene Use for the Heart (RUTH) Trial Investigators. Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes. 2013;6:164–170.CrossRefPubMed Daniels LB, Grady D, Mosca L, Collins P, et al. Raloxifene Use for the Heart (RUTH) Trial Investigators. Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes. 2013;6:164–170.CrossRefPubMed
10.
Zurück zum Zitat Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE, Manson JE. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161:242–247.CrossRefPubMed Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE, Manson JE. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161:242–247.CrossRefPubMed
11.
Zurück zum Zitat Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart. 2004;90:1398–1403.CrossRefPubMedPubMedCentral Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart. 2004;90:1398–1403.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Pajunen P, Koukkunen H, Ketonen M, et al. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia. 2005;48:2519–2524.CrossRefPubMed Pajunen P, Koukkunen H, Ketonen M, et al. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia. 2005;48:2519–2524.CrossRefPubMed
13.
Zurück zum Zitat Schramm TK, Gislason GH, Køber L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117:1945–1954.CrossRefPubMed Schramm TK, Gislason GH, Køber L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117:1945–1954.CrossRefPubMed
14.
Zurück zum Zitat Huang ES, Laiteerapoing N, Liu J, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older diabetes patients: the diabetes and aging study. JAMA Intern Med. 2014;174:251–258.CrossRefPubMedPubMedCentral Huang ES, Laiteerapoing N, Liu J, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older diabetes patients: the diabetes and aging study. JAMA Intern Med. 2014;174:251–258.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Krieger N. Overcoming the absence of socioeconomic data in medical records validation and application of a census based methodology. Am J Public Health. 1992;82:703–710.CrossRefPubMedPubMedCentral Krieger N. Overcoming the absence of socioeconomic data in medical records validation and application of a census based methodology. Am J Public Health. 1992;82:703–710.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155–2165.CrossRefPubMed Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155–2165.CrossRefPubMed
17.
Zurück zum Zitat Karter AJ, Schillinger D, Adams AS, et al. Elevated rates of diabetes in pacific islanders and Asian subgroups: the diabetes study of northern California (DISTANCE). Diabetes Care. 2013;36:574–579.CrossRefPubMedPubMedCentral Karter AJ, Schillinger D, Adams AS, et al. Elevated rates of diabetes in pacific islanders and Asian subgroups: the diabetes study of northern California (DISTANCE). Diabetes Care. 2013;36:574–579.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Karter AJ, Nundy S, Parker MM, Moffet HH, Huang ES. Incidence of remission in adults with type 2 diabetes: the diabetes & aging study. Diabetes Care. 2014;37:3188–3195.CrossRefPubMedPubMedCentral Karter AJ, Nundy S, Parker MM, Moffet HH, Huang ES. Incidence of remission in adults with type 2 diabetes: the diabetes & aging study. Diabetes Care. 2014;37:3188–3195.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–2222.CrossRef Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–2222.CrossRef
20.
Zurück zum Zitat Idris I. Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on "impact of diabetes on cardiovascular disease risk and all-cause mortality in older men". Arch Intern Med. 2011;171:410–411.CrossRefPubMed Idris I. Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on "impact of diabetes on cardiovascular disease risk and all-cause mortality in older men". Arch Intern Med. 2011;171:410–411.CrossRefPubMed
21.
Zurück zum Zitat Malik S, Budoff MJ, Katz R, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care. 2011;34:2285–2290.CrossRefPubMedPubMedCentral Malik S, Budoff MJ, Katz R, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care. 2011;34:2285–2290.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Karmali KN, Goff DC Jr, Ning H, Lloyd-Jones DM. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014;64:959–968.CrossRefPubMed Karmali KN, Goff DC Jr, Ning H, Lloyd-Jones DM. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014;64:959–968.CrossRefPubMed
23.
Zurück zum Zitat Chang TI, Leong TK, Boothroyd DB, Hlatky MA, Go AS. Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. J Am Coll Cardiol. 2014;64:985–994.CrossRefPubMed Chang TI, Leong TK, Boothroyd DB, Hlatky MA, Go AS. Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. J Am Coll Cardiol. 2014;64:985–994.CrossRefPubMed
24.
Zurück zum Zitat Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–2527.CrossRefPubMed Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–2527.CrossRefPubMed
25.
Zurück zum Zitat Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310:699–705.CrossRefPubMedPubMedCentral Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310:699–705.CrossRefPubMedPubMedCentral
Metadaten
Titel
Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events
verfasst von
Jamal S. Rana, MD, PhD
Jennifer Y. Liu, MPH
Howard H. Moffet, MPH
Marc Jaffe, MD
Andrew J. Karter, PhD
Publikationsdatum
01.04.2016
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 4/2016
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3556-3

Weitere Artikel der Ausgabe 4/2016

Journal of General Internal Medicine 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.